HONG KONG, August 31, 2026 – (ACN Newswire) – Operating Cash Flow Turns Positive for the First Time, with a Significantly Strengthened Capital StructureOn August 28, 2026, Micot Pharma (02335.HK), the first publicly listed peptide-focused innovative drug company in Hong Kong, announced its interim results for the first half of 2026.During the reporting period…
Read More
